e-Drug3D

459

ETIDRONATE

DISCONTINUED


INN
ETIDRONATE

cas 2809-21-4
CLASS

METABOLISM
BONE RESORPTION INHIBITOR
ANTIHYPOCALCEMIC AGENTS
BISPHOSPHONATES
OSTEOPOROSIS PROPHYLACTIC
IT CAN INHIBIT THE FORMATION GROWTH AND DISSOLUTION OF HYDROXYAPATITE CRYSTALS AND THEIR AMORPHOUS PRECURSORS BY CHEMISORPTION TO CALCIUM PHOSPHATE SURFACES

ROUTE (list)

ORAL INJECTION

ATC code

M05BA01
M05BB01

PK parameters

F 3 PERCENT
t1/2 3.5 HOUR

Solubility

HIGHLY SOLUBLE IN WATER


Target

TARGET FARNESYL PYROPHOSPHATE SYNTHASE

PDB
3SDV (STRUCTURE OF A THREE-DOMAIN SESQUITERPENE SYNTHASE: A PROSPECTIVE TARGET FOR ADVANCED BIOFUELS PRODUCTION)

Ligand code = 911 (link to the list of PDB complexes)

Download experimental 3D coordinates of 911 with added hydrogens

DrugCentral

Type IV secretion-like conjugative transfer relaxase protein TraI UNIPROT B1LRJ1 traI

Download SDF file (1-hydroxy-1-phosphonoethyl)phosphonic acid

Formula:
C2H8O7P2

Calculated chemical properties:

MW 201.99
NB_atoms 11
XLogP -3.52
PSA 134.201
NB_HD 1
NB_HA 7
fsp3 1.00
Lipinski(0=no;1=yes) 1

FDA
NDA 017831 (pdf not found) INN (ETIDRONATE DISODIUM) DIDRONEL (APIL) APPROVAL= AP YEAR= 1977 NEWMOLECULARENTITY DISCONTINUED
NDA 019545 (pdf not found) INN (ETIDRONATE DISODIUM) DIDRONEL (MGI PHARMA INC) APPROVAL= AP YEAR= 1987 DISCONTINUED
NDA 075800 (pdf not found) INN (ETIDRONATE DISODIUM) ETIDRONATE DISODIUM (NORVIUM BIOSCIENCE) APPROVAL= AP YEAR= 2003 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL